Skip to main content
Ramy Hanna, MD, Nephrology, Orange, CA

RamyMagdyHannaMDFASN FACP

Nephrology Orange, CA

Associate Clinical Professor of Medicine and Nephrology, principal investigator, fellowship program director

Dr. Hanna is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Hanna's full profile

Already have an account?

  • Office

    101 The City Dr S
    Orange, CA 92868
    Phone+1 714-880-7812

Summary

  • I am a board certified general nephrologist and internist engaged in academic research and practice.

Education & Training

  • Olive View/UCLA Medical Center
    Olive View/UCLA Medical CenterFellowship, Nephrology, 2010 - 2012
  • Olive View/UCLA Medical Center
    Olive View/UCLA Medical CenterResidency, Internal Medicine, 2007 - 2010
  • University of California San Diego School of Medicine
    University of California San Diego School of MedicineClass of 2007
  • University of California Los Angeles (UCLA)
    University of California Los Angeles (UCLA)BS, Microbiology Immunology and Molecular Genetics (MIMG), Summa Cum Laude, 1999 - 2003

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2009 - 2026
  • American Board of Internal Medicine Nephrology
  • ICHICH Good Clinical Practice for Clinical Trial Sites
  • UCLABiomedical Research Practices/HIPPA Certification

Awards, Honors, & Recognition

  • FACP ACP, 2017
  • FASN ASN, 2017
  • Phi-Beta-Kappa UCLA, 2003
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Eight-Week Hepatitis C Treatment with New Direct Acting Antivirals Has a Better Safety Profile While Being Effective in the Treatment-Naïve Geriatric Population Withou...  
    Francisco Durazo, Ramy M Hanna, Beshoy Yanny, Digestive Diseases and Sciences
  • Patient with impaired glucose tolerance and hypertension shown to have moderately advanced diabetic nephropathy on renal biopsy  
    Ramy M. Hanna, Proceedings of UCLA Health
  • Reverse pseudohyperkalemia complicating management in a patient with chronic kidney disease  
    Ramy m Hanna MD Rumi Cader MD, Proceedings of Ucla Health
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • 3 patients with injection of intravitreal Vascular Endothelial Growth Factor (VEGF) inhibitors and subsequent exacerbation of chronic proteinuria and hypertension: Int...
    Hanna RM, Lopez E, Hasnain H, Selamet U, Wilson J, Ekladious Y, Bunnapradist S, Gorin, NKF Research Day, 1/1/2018
  • 3 patients with injection of intravitreal Vascular Endothelial Growth Factor (VEGF) inhibitors and subsequent exacerbation of chronic proteinuria and hypertension: Int...
    Hanna RM, Lopez E, Hasnain H, Selamet U, Wilson J, Ekladious Y, Bunnapradist S, Gorin, UCLA DOM Research Day/NKF Research Day, 1/1/2018
  • Secondary membranous nephropathy associated with Anti MUSK related myasthenia gravis
    Hanna RM, Kaldas M, NKF, 1/1/2018
  • Join now to see all

Lectures

  • Diabetes and your kidneys-a patient education seminar 
    Rancho Palos Verdes YMCA - 2/21/2018
  • Guest panelist regarding atypical HUS diagnosis. 
    Alexion Pharmaceuticals
  • VEGF nephrotoxicity 
    UCLA RRMC
  • Join now to see all

Other

Committees

  • Conducted fellow-candidate Interviews, UCLA Nephrology 2017 - Present
  • Patient Safety Comittee member, Long Beach Memorial 2016 - Present
  • UCLA-Health Clinical Research Consortium, UCLA Nephrology

Research History

  • Journal Peer Reviewer and EditorSJKDT,International Journal of STD and AIDS, BJMMR, HIV and palliative care, Permanente Journal, AJMH, Journal of advances in medicine, JSSR, Reviewer and Editor ‘South Asian Journal of Research in Nephrology’2012 - Present
  • Clinical ResearchOngoing efforts in clinical research ,description of novel pathology, and clinical trials as above2010 - Present
  • PIIntravitreal VEGF inhibitor effects on HTN and proteinuria in Diabetics with CKD IRB#17-001284
  • Co-PIAcute kidney injury after off label mitra-clip device tricupsid valve repair IRB#17-001845
  • Co-PISodium correction with very low dose tolvaptan IRB# 17-001783

Professional Memberships

Other Languages

  • Arabic, Spanish

Industry Relationships

  • Speaker, AlexionSpeaker for SolirisDisclosure: Part of 2018 Speaker's Bureau